Hearing News Watch

VIENNA, AUSTRIA — A recent study led by a research team at MedUni Vienna highlights the potential of AC102, a new active substance that could mark a significant advancement in the treatment of acute hearing disorders, including sudden hearing loss. The promising findings, published in Cell Death & Disease, stem from preclinical trials and offer a glimpse of hope for

BALLERUP, DENMARK – GN today announced the release its Interim Report for Q3 2024. The company experienced further margin expansion and strong cash flow, despite facing varying growth trends across its divisions. Financial Highlights and Strategic Initiatives Hearing Division: Achieved 10% organic revenue growth, fueled by market share gains and the continued success of the ReSound Nexia product line. The

Western Australian innovators have developed ClearDrum, the world’s first prosthetic device designed to repair chronic ruptured eardrums, a significant advancement with global implications for ear health. Lead researcher Dr. Filippo Valente has secured $143,316 (AUD) in funding from the state government to prepare for manufacturing and clinical trials of this groundbreaking technology. ClearDrum is an implantable prosthetic eardrum made using

In its Q3 2024 Interim Management Statement, Demant announced an organic revenue growth of 2%, primarily supported by strong performance in its Hearing Care segment. Despite increased competition and challenging market dynamics, Demant’s proactive cost-saving measures helped to stabilize expenses, positioning the company to meet its projected annual targets. Financial Performance and Revenue Breakdown The Group achieved total revenue of

IRVINE, CALIFORNIA – InnoCaption, a leading mobile call captioning technology provider for the Deaf and hard of hearing community, announced today that it has completed the acquisition of CaptionMate. Certified and funded by the Federal Communications Commission (FCC), both InnoCaption and CaptionMate provide eligible end users with free mobile app-based call captioning services. CaptionMate uses advanced automated speech recognition technology

MILAN, ITALY — Amplifon S.p.A. has reported impressive financial results for Q3 2024, showcasing solid growth despite challenging market conditions in Europe. With a focus on expanding its footprint worldwide, Amplifon’s strategic acquisitions and investment in its retail network have played a central role in driving revenue and boosting EBITDA. Key Financial Highlights For the first nine months of 2024,

HOUSTON, TEXAS — The greater Houston metropolitan area now has more access to better hearing health with the news that leading hearing care retailer HearUSA has opened two modern hearing centers in the area, Westchase (2691-B Wilcrest Drive) in March, and Bay Forest (1956 El Dorado Boulevard Unit 10) in May. The opening is part of HearUSA’s initiative to expand

The 68th EUHA Congress, held in Hanover from October 16-18, 2024, brought together approximately 8,700 participants, surpassing attendance expectations. As the world’s largest hearing acoustics industry event, the congress featured over 130 exhibitors, 26 expert presentations, five tutorials, a specialized “Future Friday” program, free admission for trainees and students, and the new EUHA Live Area. The congress opened with speeches

MILANO – Amplifon has launched a new awareness campaign in Italy and Spain, showcasing the emotional richness of life that hearing care can restore. Titled “Un test dell’udito speciale” (A Special Hearing Test), the campaign highlights real Amplifon clients reacting to surprise messages from loved ones during a routine hearing test. These genuine, unscripted moments emphasize how hearing restoration brings

A new study published in the Journal of the American Heart Association highlights a possible link between sensory impairments, specifically hearing and vision loss, and an elevated risk of cardiovascular diseases, including stroke and heart attacks. Conducted by researchers at Jiangnan University’s Wuxi School of Medicine, the study analyzed data from over 11,000 Chinese adults aged 45 and older and